Fortunately, in the current practice, granulocyte colony-stimulating factor (GCSF) and new generation antibiotics are available that can effectively treat and prevent leukopenia, so the efforts to predict neutropenia and lymphopenia during chemoradiation are of great value [35]. The gene discussed is CSF3; the disease is lymphopenia.